MetLife (MET) Director Jeh C. Johnson Receives 59 Shares

What Happened

• Jeh C. Johnson, a director of MetLife, was credited with 59 shares of MetLife common stock on 2026-09-08 as an award/acquisition (code A). The shares are valued at $95.50 each, for a total of $5,635.
• This transaction reflects an imputed reinvestment of dividends into deferred shares under MetLife’s Deferred Compensation Plan for Non‑Management Directors — a routine administrative credit rather than an open‑market purchase.

Key Details

• Transaction date and price: 2026-09-08 at $95.50 per share (59 shares; $5,635 total).
• Filing: Form 4 filed 2026-09-10 (appears timely under Form 4 reporting rules).
• Shares owned after transaction: Not specified in the filing.
• Footnote: F1 — imputed reinvestment of dividends on deferred shares; these are shares that became payable but the director deferred receipt under the director deferred compensation plan.
• Transaction code: A (award/grant or other acquisition).

Context

• This type of transaction is typically routine bookkeeping for dividend reinvestment in a deferred compensation plan and does not imply an active market purchase or sale by the director.
• The dollar amount is modest ($5.6k) relative to typical insider trades and should be viewed as administrative compensation treatment rather than a directional signal.